Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 25.93 CNY -5.57% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Relative Value

The Relative Value of one Beijing Kawin Technology Share-holding Co Ltd stock under the Base Case scenario is 44.27 CNY. Compared to the current market price of 25.93 CNY, Beijing Kawin Technology Share-holding Co Ltd is Undervalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
44.27 CNY
Undervaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
27
vs Industry
75
Median 3Y
3
Median 5Y
2.7
Industry
7.7
Forward
2.7
vs History
42
vs Industry
5
Median 3Y
35.2
Median 5Y
32.6
Industry
22.2
Forward
31
vs History
17
vs Industry
8
Median 3Y
27.4
Median 5Y
25.8
Industry
22.3
vs History
23
vs Industry
5
Median 3Y
25.6
Median 5Y
-38.7
Industry
25.5
vs History
38
vs Industry
39
Median 3Y
2.4
Median 5Y
2.4
Industry
2.5
vs History
25
vs Industry
68
Median 3Y
2.2
Median 5Y
1.9
Industry
7.8
Forward
2.1
vs History
25
vs Industry
66
Median 3Y
2.6
Median 5Y
2.2
Industry
9
vs History
55
vs Industry
6
Median 3Y
23.7
Median 5Y
22.1
Industry
3.9
Forward
16.5
vs History
55
vs Industry
6
Median 3Y
23.7
Median 5Y
22.1
Industry
3.6
Forward
13.9
vs History
17
vs Industry
9
Median 3Y
19.4
Median 5Y
15.7
Industry
5.2
vs History
vs Industry
3
Median 3Y
-28.5
Median 5Y
-39.8
Industry
3.3
vs History
59
vs Industry
38
Median 3Y
3.8
Median 5Y
3.7
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Beijing Kawin Technology Share-holding Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
4.3B CNY 3.1 32.3 19.5 19.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.4B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 11 -243 24.2 25.5
US
Gilead Sciences Inc
NASDAQ:GILD
112.5B USD 4 892.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.3B USD 6 17.7 16.1 17.9
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average P/E: 179.1
32.3
116%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -243
42%
US
Gilead Sciences Inc
NASDAQ:GILD
892.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBITDA: 17.6
19.5
166%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBIT: 22.1
19.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top